Sphera Funds Management
Latest statistics and disclosures from Sphera Funds Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, NICE, TSEM, CDTX, MRUS, and represent 22.51% of Sphera Funds Management's stock portfolio.
- Added to shares of these 10 stocks: NICE (+$23M), MRUS (+$14M), QQQ (+$14M), QURE (+$5.8M), CLBT (+$5.5M), Solaredge Technologies (+$5.3M), RAPP, VRNS, CDTX, GPCR.
- Started 24 new stock positions in CMMB, RVMD, AVGO, MIST, RAPP, IMNM, MRUS, QQQ, WVE, IDYA. QURE, MDWD, Solaredge Technologies, VYGR, VRNS, SLNO, TECX, DSGN, CLBT, SABS, PCVX, ROIV, ENPH, NICE.
- Reduced shares in these 10 stocks: SNDX (-$18M), , NVMI (-$10M), MLYS (-$9.9M), CYTK (-$9.1M), NVDA (-$8.6M), ARWR (-$6.6M), MSFT (-$5.9M), Ormat Technologies (-$5.6M), TVTX (-$5.6M).
- Sold out of its positions in AMAT, RNA, Chemomab Therapeutics, ELEV, NTLA, KZR, KRYS, MRVL, MSFT, NNDM. NVDA, Ormat Technologies, PANW, XBI, CRM, SRRK, S, SLDB, UBER, VTGN, CGNT, CYBR, WIX.
- Sphera Funds Management was a net seller of stock by $-51M.
- Sphera Funds Management has $474M in assets under management (AUM), dropping by 11.25%.
- Central Index Key (CIK): 0001496201
Tip: Access up to 7 years of quarterly data
Positions held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 105 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.4 | $30M | -7% | 1.5M | 20.20 |
|
| Nice Sponsored Adr (NICE) | 4.8 | $23M | NEW | 157k | 144.78 |
|
| Tower Semiconductor Shs New (TSEM) | 4.8 | $23M | +17% | 312k | 72.30 |
|
| Cidara Therapeutics Com New (CDTX) | 3.5 | $17M | +27% | 176k | 95.76 |
|
| Merus N V Call Option (MRUS) | 3.0 | $14M | NEW | 150k | 94.15 |
|
| NOVA MEASURING Instruments L (NVMI) | 3.0 | $14M | -42% | 44k | 319.66 |
|
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 2.9 | $14M | NEW | 23k | 600.37 |
|
| Biogen Idec (BIIB) | 2.4 | $12M | 83k | 140.08 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 2.2 | $11M | +25% | 353k | 30.08 |
|
| Astrazeneca Sponsored Adr (AZN) | 2.2 | $10M | 135k | 76.72 |
|
|
| Sanofi Sa Sponsored Adr (SNY) | 2.2 | $10M | 220k | 47.20 |
|
|
| Cytokinetics Com New (CYTK) | 1.9 | $8.9M | -50% | 162k | 54.96 |
|
| Bridgebio Pharma (BBIO) | 1.9 | $8.9M | +24% | 171k | 51.94 |
|
| Mineralys Therapeutics (MLYS) | 1.8 | $8.3M | -54% | 220k | 37.92 |
|
| Amicus Therapeutics (FOLD) | 1.6 | $7.8M | 991k | 7.88 |
|
|
| Eli Lilly & Co. (LLY) | 1.6 | $7.7M | -12% | 10k | 763.00 |
|
| Johnson & Johnson (JNJ) | 1.6 | $7.6M | 41k | 185.42 |
|
|
| Forte Biosciences Com New (FBRX) | 1.5 | $7.1M | -4% | 474k | 15.00 |
|
| Trevi Therapeutics (TRVI) | 1.5 | $7.1M | -3% | 773k | 9.15 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $6.3M | +133% | 224k | 28.00 |
|
| Syndax Pharmaceuticals (SNDX) | 1.3 | $6.0M | -75% | 388k | 15.38 |
|
| Novo-nordisk A S Adr (NVO) | 1.2 | $5.9M | 106k | 55.49 |
|
|
| Abbvie (ABBV) | 1.2 | $5.8M | 25k | 231.54 |
|
|
| Uniqure Nv SHS (QURE) | 1.2 | $5.8M | NEW | 100k | 58.37 |
|
| Praxis Precision Medicines I Com New (PRAX) | 1.2 | $5.7M | -48% | 108k | 53.00 |
|
| Cellebrite Di Ordinary Shares (CLBT) | 1.2 | $5.5M | NEW | 299k | 18.53 |
|
| Annexon (ANNX) | 1.2 | $5.5M | 1.8M | 3.05 |
|
|
| Dyne Therapeutics (DYN) | 1.1 | $5.4M | +92% | 427k | 12.65 |
|
| Celldex Therapeutics Com New (CLDX) | 1.1 | $5.4M | -50% | 208k | 25.87 |
|
| Solaredge Technologies Note 2.250% 7/0 | 1.1 | $5.3M | NEW | 4.0M | 1.33 |
|
| GSK Sponsored Adr (GSK) | 1.1 | $5.3M | 122k | 43.16 |
|
|
| Solaredge Technologies (SEDG) | 1.1 | $5.2M | +10% | 141k | 37.00 |
|
| Oric Pharmaceuticals (ORIC) | 1.1 | $5.2M | +9% | 432k | 12.00 |
|
| Immatics SHS (IMTX) | 1.0 | $5.0M | 583k | 8.52 |
|
|
| Savara (SVRA) | 1.0 | $4.8M | +3% | 1.4M | 3.57 |
|
| Novartis Sponsored Adr (NVS) | 1.0 | $4.7M | 37k | 128.24 |
|
|
| Rapport Therapeutics (RAPP) | 1.0 | $4.7M | NEW | 158k | 29.70 |
|
| Varonis Sys (VRNS) | 0.9 | $4.2M | NEW | 74k | 57.47 |
|
| Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT) | 0.9 | $4.2M | 47k | 89.37 |
|
|
| Immunovant (IMVT) | 0.9 | $4.1M | 257k | 16.12 |
|
|
| Merck & Co (MRK) | 0.9 | $4.1M | 49k | 83.93 |
|
|
| Maze Therapeatics (MAZE) | 0.8 | $4.0M | -56% | 154k | 25.93 |
|
| Eledon Pharmaceuticals (ELDN) | 0.8 | $3.8M | -25% | 1.5M | 2.59 |
|
| Engene Holdings (ENGN) | 0.7 | $3.4M | 504k | 6.83 |
|
|
| Elbit Sys Ord (ESLT) | 0.7 | $3.4M | +12% | 6.7k | 509.80 |
|
| Rezolute Com New (RZLT) | 0.7 | $3.4M | -51% | 364k | 9.40 |
|
| Enliven Therapeutics (ELVN) | 0.7 | $3.4M | +29% | 167k | 20.47 |
|
| Mediwound Shs New (MDWD) | 0.7 | $3.3M | NEW | 185k | 18.02 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $3.2M | -14% | 149k | 21.34 |
|
| Camtek Ord (CAMT) | 0.6 | $3.1M | -9% | 29k | 105.05 |
|
| Amazon (AMZN) | 0.6 | $3.0M | -57% | 14k | 219.57 |
|
| Corvus Pharmaceuticals (CRVS) | 0.6 | $3.0M | +122% | 408k | 7.37 |
|
| Pharvaris N V (PHVS) | 0.6 | $3.0M | -61% | 119k | 24.95 |
|
| Roivant Sciences SHS (ROIV) | 0.6 | $2.9M | NEW | 194k | 15.13 |
|
| Sarepta Therapeutics Call Option (SRPT) | 0.6 | $2.9M | -51% | 150k | 19.27 |
|
| Meta Platforms Cl A (META) | 0.6 | $2.9M | -53% | 3.9k | 734.38 |
|
| Soleno Therapeutics (SLNO) | 0.6 | $2.8M | NEW | 42k | 67.60 |
|
| Revolution Medicines (RVMD) | 0.6 | $2.8M | NEW | 60k | 46.70 |
|
| Ormat Technologies (ORA) | 0.6 | $2.8M | -62% | 29k | 96.25 |
|
| Ideaya Biosciences (IDYA) | 0.6 | $2.7M | NEW | 100k | 27.21 |
|
| Amgen (AMGN) | 0.6 | $2.7M | 9.5k | 282.20 |
|
|
| Advanced Micro Devices (AMD) | 0.5 | $2.5M | +87% | 16k | 161.79 |
|
| Travere Therapeutics Call Option (TVTX) | 0.5 | $2.4M | -69% | 102k | 23.90 |
|
| Alpha Cognition Com New (ACOG) | 0.5 | $2.2M | -10% | 339k | 6.51 |
|
| Pfizer (PFE) | 0.5 | $2.2M | 86k | 25.48 |
|
|
| Cybin Com New (CYBN) | 0.5 | $2.2M | -7% | 370k | 5.89 |
|
| Kura Oncology (KURA) | 0.5 | $2.2M | +4% | 246k | 8.85 |
|
| Broadcom (AVGO) | 0.5 | $2.2M | NEW | 6.6k | 329.91 |
|
| Ceva (CEVA) | 0.5 | $2.1M | +65% | 81k | 26.41 |
|
| Janux Therapeutics (JANX) | 0.4 | $2.1M | 86k | 24.44 |
|
|
| Skye Bioscience Com New (SKYE) | 0.4 | $1.9M | -11% | 479k | 3.93 |
|
| Astria Therapeutics (ATXS) | 0.4 | $1.8M | -2% | 251k | 7.28 |
|
| Tectonic Therapeutic (TECX) | 0.4 | $1.8M | NEW | 116k | 15.69 |
|
| Vaxcyte (PCVX) | 0.4 | $1.8M | NEW | 50k | 36.02 |
|
| Perspective Therapeutics Com New (CATX) | 0.4 | $1.8M | +64% | 510k | 3.43 |
|
| Immunome (IMNM) | 0.4 | $1.7M | NEW | 147k | 11.71 |
|
| Milestone Pharmaceuticals (MIST) | 0.3 | $1.6M | NEW | 820k | 2.00 |
|
| Jasper Therapeutics Com New (JSPR) | 0.3 | $1.5M | +4190% | 630k | 2.38 |
|
| Apellis Pharmaceuticals (APLS) | 0.3 | $1.4M | -44% | 64k | 22.63 |
|
| Cogent Biosciences (COGT) | 0.3 | $1.4M | -71% | 99k | 14.36 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.3 | $1.4M | 22k | 65.00 |
|
|
| Ventyx Biosciences (VTYX) | 0.3 | $1.4M | -20% | 440k | 3.11 |
|
| Biohaven (BHVN) | 0.3 | $1.4M | -37% | 91k | 15.01 |
|
| Bicara Therapeutics (BCAX) | 0.3 | $1.4M | +30% | 86k | 15.79 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $1.3M | -2% | 408k | 3.27 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.3 | $1.2M | 175k | 7.05 |
|
|
| Werewolf Therapeutics (HOWL) | 0.3 | $1.2M | 627k | 1.97 |
|
|
| Sab Biotherapeutics Com New (SABS) | 0.2 | $1.1M | NEW | 566k | 2.01 |
|
| 4068594 Enphase Energy (ENPH) | 0.2 | $945k | NEW | 27k | 35.39 |
|
| Voyager Therapeutics (VYGR) | 0.2 | $933k | NEW | 200k | 4.67 |
|
| Eliem Therapeutics (CLYM) | 0.2 | $874k | +107% | 435k | 2.01 |
|
| Larimar Therapeutics (LRMR) | 0.2 | $841k | +32% | 260k | 3.23 |
|
| Pepgen (PEPG) | 0.2 | $792k | +9% | 172k | 4.62 |
|
| Bristol Myers Squibb (BMY) | 0.2 | $789k | 18k | 45.10 |
|
|
| Verastem Com New (VSTM) | 0.1 | $692k | -52% | 78k | 8.83 |
|
| 89bio (ETNB) | 0.1 | $583k | -80% | 40k | 14.70 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $581k | -35% | 81k | 7.17 |
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $472k | NEW | 179k | 2.63 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $431k | -93% | 13k | 34.49 |
|
| Aprea Therapeutics Com New (APRE) | 0.1 | $398k | 270k | 1.48 |
|
|
| Wave Life Sciences SHS (WVE) | 0.1 | $366k | NEW | 50k | 7.32 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $166k | 61k | 2.75 |
|
|
| Design Therapeutics (DSGN) | 0.0 | $165k | NEW | 22k | 7.53 |
|
| Promis Neurosciences Com New (PMN) | 0.0 | $126k | -84% | 295k | 0.42 |
|
| Applied Therapeutics (APLT) | 0.0 | $30k | 50k | 0.60 |
|
Past Filings by Sphera Funds Management
SEC 13F filings are viewable for Sphera Funds Management going back to 2013
- Sphera Funds Management 2025 Q3 filed Nov. 14, 2025
- Sphera Funds Management 2025 Q2 filed Aug. 14, 2025
- Sphera Funds Management 2025 Q1 filed May 15, 2025
- Sphera Funds Management 2024 Q4 filed Feb. 14, 2025
- Sphera Funds Management 2024 Q3 filed Nov. 14, 2024
- Sphera Funds Management 2024 Q2 filed Aug. 14, 2024
- Sphera Funds Management 2024 Q1 filed May 15, 2024
- Sphera Funds Management 2023 Q4 restated filed Feb. 15, 2024
- Sphera Funds Management 2023 Q4 filed Feb. 14, 2024
- Sphera Funds Management 2023 Q3 filed Nov. 14, 2023
- Sphera Funds Management 2023 Q2 filed Aug. 14, 2023
- Sphera Funds Management 2023 Q1 filed May 15, 2023
- Sphera Funds Management 2022 Q4 filed Feb. 14, 2023
- Sphera Funds Management 2022 Q3 filed Nov. 14, 2022
- Sphera Funds Management 2022 Q2 filed Aug. 15, 2022
- Sphera Funds Management 2022 Q1 filed May 16, 2022